Sengenics Awarded Prestigious Michael J. Fox Foundation Grant to Determine the Role of Autoantibodies in the Progression of Parkinson's - Press Release
Dec 15, 2020 14:00 UTC Sengenics Awarded Prestigious Michael J. Fox Foundation Grant to Determine the Role of Autoantibodies in the Progression of Parkinson’s LONDON--(Business Wire)--Sengenics, the Functional Proteomics Company, has been awarded a prestigious research grant by The Michael J. Fox Foundation for Parkinson's Research (MJFF) to identify novel autoantibody signatures related to non-motor symptoms in individuals with high risk of Parkinson’s disease (PD) from the Parkinson’s Associated Risk Study (PARS). The objective of the study will be to leverage KREX-based Immunome pr...
Source: digitaljournal.com